Introduction
The potentially lethal monogenic anaemia β-thalassaemia requires lifelong and costly disease management [1] ; therefore, national screening and prevention programmes are crucial to countries with a high proportion of disease carriers. The latter present haematologically with characteristically low mean cell volume and, through depletion of β-globin and thus the main adult haemoglobin Hb A (α 2 β 2 ), show an increase in the minor adult haemoglobin Hb A 2 (α 2 δ 2 ) from 2.5-3.0% to above 3.5% of total haemoglobin [2] . In consequence, δ-globin expression is central to the haematological diagnosis of thalassaemias. This is exemplified by the situation in which double heterozygotes for δ-and β-thalassaemia present with an atypical phenotype characterized by microcytosis and hypochromia, but with normal Hb A 2 , similar to certain α-thalassaemia heterozygotes. In countries such as Cyprus, where the occurrence of α-, β-and δ-thalassaemia mutations is common [3] , the presence of δ-thalassaemia masks the typical β-thalassaemia phenotype and thus interferes with population screening for β-thalassaemia carriers [4] . Cases with borderline or abnormal haematological findings are, therefore, routinely undergoing molecular analysis of the δ-globin gene as well. This allows a definitive diagnosis and safeguards disease prevention and national disease control for thalassaemia on the one hand, while on the other hand continuously accumulating and updating a comprehensive catalogue of mutations in the respective population [5] . Here, we report a novel δ-globin gene variant, Hb A 2 [δ A142V ]
or Hb A 2 Episkopi, unresolved by cellulose acetate electrophoresis (CAE) but detectable by cationexchange high-performance liquid chromatography (CE-HPLC), presenting in a normal genetic background of a family with mixed Lebanese-Cypriot descent.
Materials and methods

Subjects
Study subjects were analyzed between 2011 and 2013 as part of the national thalassaemia prevention programme of the Republic of Cyprus and have given full informed consent for their inclusion in this study.
Haematological analyses
Haematological studies were performed using routine methods. Haemoglobin analysis and detection of Hb A 2 Episkopi were achieved by CE-HPLC on the β-thalassaemia VARIANT™ program (Bio-Rad Life Sciences), while employment of an alternative HPLC system (Shimadzu) (see online supplementary material Fig. S1 ) and of standard CAE procedures and equipment (Helena Laboratories) had failed to do so. Additional post-analysis HPLC peak quantification was performed using FiJi ImageJ 1.49 [6] .
Molecular analyses
Nucleotide and amino-acid numbers are given with RefSeq NG_000007 as reference for genomic DNA positions and NM_000519.3 as reference for human HBD cDNA and predicted amino-acid sequences. By convention in the haemoglobin field and contrary to guidelines of the Human Genome Variation Society (HGVS), aminoacid references do not count the initiating methionine, absent in the mature protein, and therefore differ by −1 from corresponding HGVS position references. In addition to the analyses in the δ-globin gene HBD, the specific study subjects were tested for -α 3.7 , ααα, α -5nt α, αAgrα, α PolyA1 α and α PolyA2 α mutations of the α-globin locus [7] and for any mutations in the β-globin locus between 288 nt upstream of the HBB start codon and 240 nt downstream of the HBB stop codon [3] . Mutations in HBD were detected by sequencing of two overlapping PCR fragments. The first fragment of 1161 bp was amplified with primers δF1: ithanet.eu) [8] .
Bioinformatics and statistical analyses
In silico protein-structure and stability analyses were based on RCSB PDB entry 1si4 of the relaxed (R2) state of normal Hb A 2 [9] . Modelling of normal and variant Hb A 2 was performed by FoldX3.0 in command-line mode [10] for the creation and energy-optimization of variants, and using YASARA [11] and the POV-Ray rendering tool (www.povray. org) for rendering of images. Structure-dependent comparative energy calculations for tetramers by FoldX assumed default conditions, including a temperature of 37°C and a pH of 7, and used five iterations to calculate averages and standard deviations of energy differences (kcal mol -1 ) between variant and normal Hb A 2 . The significance of changes in Hb A 2 was assessed for each test case against a reference population of individuals matched for gender and α-and β-globin genotype, using the Microsoft Excel NORM.DIST function. The isoelectric point (pI) for all δ-globin variants and pI differences for variants compared to normal δ-globin are based on the protein pI estimate of the Isoelectric Point Calculator (IPC) [12] .
Results
An index case presenting with anatomical and haematological abnormalities
The index case (M1) from Episkopi of the Limassol district of Cyprus was first seen at the age of 1 month for evaluation regarding cryptorchidism and a U-shaped cleft palate. The proband had, in addition, deep-set, hypoplastic toe-nails, but otherwise his evaluation was unremarkable. Review of the family history revealed that the child was born to healthy, non-consanguineous parents of mixed Cypriot-Lebanese descent, with a family history non-contributory for clefting but contributory on the maternal side for cryptorchidism. These findings indicated more comprehensive analyses, which revealed an apparently normal male karyotype, normal biochemistry, ophthalmology, cardiology and ultrasound scan of the abdomen, while array-CGH revealed a maternally inherited duplication of 0.78 Mb, on chromosome 1 on chromosomal band 1q44, location: 244,935,100-245,724,786 [build GRCh37 (hg19)] [arr 1q44(244,935,100-245,724,786)x3 mat], the clinical significance of which remains unclear. The father was unavailable for testing.
Subsequent analyses of blood smears and a duplicate complete blood count (CBC) for the index case at 10 months of age and for his mother (F1), aged 33, in both cases revealed mild hypochromic, microcytic anaemia. Mean cell volume (73.3 fl and 78.5 fl) and mean cell haemoglobin (24.6 pg and 26.7 pg) for M1 and F1, respectively, were slightly below the reference range, while other CBC parameters and indices for iron deficiency (zinc protoporphyrin and RDW-CV) were in the normal range (Table 1) . CAE analysis showed reduced Hb A 2 for F1 but normal levels for M1 (Table 1) , each compared to the age-matched (and for the mother gender-matched) reference range. However, CE-HPLC analysis revealed a split peak for Hb A 2 , indicating a novel stable Hb A 2 variant (with 87% the peak area of normal Hb A 2 ) and prompting molecular analyses.
Confirmation of the novel δ-globin variant by sequence analysis
Comprehensive globin sequence analysis and gap-PCR [13] of the index case M1 revealed heterozygosity for a hitherto unreported δ-globin mutation (Figure 1(a) ), in the absence of any of the other α-or β-globin mutations tested, with identical findings for F1. Mutations in the globin loci are, therefore, not responsible for the slightly abnormal or borderline haematology of M1 and F1. The novel δ-globin missense mutation introduces a codon change GCT > GTT (alanine to valine) at codon 143 of the HBD gene (and thus at amino acid 142 of the mature δ-globin protein). For the same nucleotide position, an alternative GCT > GAT mutation has been characterized before and brings about an amino acid change of alanine to aspartate, giving rise to HbA 2 Fitzroy instead [14] .
Predicted and observed consequences of the amino-acid substitution HBD:c.428C > T is the mutation closest to the 3 ′ end of the δ-globin gene yet reported in Cyprus [15] , positioning the affected amino-acid at the transition of the final α-helix of δ-globin towards the flexible carboxy-terminus. The predicted A > V amino-acid change from one non-polar, uncharged aliphatic side chain to another maintains the predicted isoelectric point (pI) of 7.42 for the resultant variant δ-globin (see Table 2 ) [12] , in contrast to the HBD:c.428C > A mutation underlying HbA 2 Fitzroy [14] , which results in an A > D aminoacid change and a predicted pI of 6.87. This is in line with an inability to detect the new Hb A 2 [δA142V] variant by the charge-dependent method of CAE in the basic heterozygote state, necessitating detection of a split peak by CE-HPLC (Figure 1(b) ) to avoid possible misdiagnosis, while the more acidic HbA 2 Fitzroy is readily detectable by CAE [14] . The properties of both alternative same-residue variants are compared in Table 3 . Of note, elevated oxygen affinity was inferred for Hb Fitzroy from the equivalent Hb A variant Hb Ohio (Hb A[βA142D]) [16] , and we likewise infer for Hb Episkopi that it will have elevated oxygen affinity, as was shown for its paralogous β-globin variant Hb Waterland (Hb A[βA142V]) [17] . For the Hb A 2 Episkopi heterotetramer, structure-based stability prediction gives only subtle changes in the predicted protein backbone of the heterotetramer but indicates a moderately destabilizing effect of the mutation (see Figure 1 (c) and Table  2 ), which agrees with the observed steady-state abundance of the new variant being slightly below that of normal Hb A 2 in the heterozygote state .
Discussion
Here, we have described and sequenced a novel δ-globin variant in a family of mixed Cypriot-Lebanese descent and named after the family's place of residence, Hb A 2 Episkopi. Experimental CE-HPLC data and stability predictions suggest that the variant is slightly destabilized compared to normal Hb A 2 and is readily detectable as an additional peak (albeit without baseline separation) on suitable HPLC systems. This description of Hb A 2 Episkopi increases the heterogeneity of the δ-globin gene in Cyprus from 15 to 16 alleles [3] , including 11 variants. Of routine laboratory methods, CE-HPLC is able to discern Hb A 2 [δA142V] from normal Hb A 2 where a suitable CE-HPLC system is available, owing to the variant's stability and its overall charge, while CAE fails to detect the variant. This is in contrast to HbA 2 Fitzroy (Hb A 2 [δA142D]), which results from an alternative missense mutation of the same codon and is readily detectable by CAE [14] . Our observations once more emphasize the need to employ multiple analysis methods for the routine detection of haemoglobin variants, which also applies to environments without Reference ranges are normal ranges for children of 0.5-2 years and for adult women, respectively [20] . αα/αα, N/N -diagnosed homozygous normal according to haematological sample parameters, respectively, for the α-globin locus and for the β-globin locus after the detection assays specified in the section 'Materials and methods'. *In agreement with literature references [20] , Hb A 2 levels for F1 are slightly but significantly below gender-matched control levels of the respective reference population in Cyprus (p = 0.033), in contrast to those for M1 (p = 0.495). The underlying cause is unknown.
access to HPLC equipment, where complementary electrophoresis methods might be used instead. For instance, the combination of methods detecting changes in pI or in charge at a given pH, such as isoelectric focussing (IEF) or CAE [18, 19] , could be combined with methods detecting changes in molecular weight, such as acid-urea-Triton X-100 polyacrylamide gel electrophoresis (AUT-PAGE) [19] , to minimize false-negative variant detection and thus the risk of misdiagnosis of haemoglobinpathies. With this paper, we have established the detection and identity of the novel δ-globin variant Hb A 2 Episkopi, which may lead to the targeted discovery of the same sequence variant in other, and in particular Lebanese, populations.
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field of haemoglobinopathies and of thalassaemia in particular. 
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